Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Intec Pharma Ltd. (NTEC) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/05/2020 8-K Quarterly results
Docs: "Intec Pharma Reports Third Quarter 2020 Financial Results and Provides Corporate Update JERUSALEM - Intec Pharma Ltd. today announces financial results for the third quarter ended September 30, 2020 and provides a corporate update. “We maintain our focus on executing strategic partnerships and collaborations. As such, we were delighted in recent weeks to announce a new research collaboration with Merck. While we are unable to provide the specifics of the agreement, it speaks to Merck’ s keen understanding of the Accordion Pill technology and their continued interest in working with us to realize its potential,” stated Jeffrey A. Meckler, Vice Chairman and Chief Executive Officer of Intec Pharma. “In addition, we continue to innovate and progress our next generation gastric retentive techn..."
08/05/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
Docs: "Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update JERUSALEM - Intec Pharma Ltd. today announces financial results for the first quarter ended March 31, 2020 and provides a corporate update. Highlights from the Quarter and Recent Weeks"
11/12/2019 8-K Quarterly results
08/09/2019 8-K Quarterly results
Docs: "Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update Jerusalem – Intec Pharma Ltd. today announces financial results for the three and six months ended June 30, 2019. Highlights of the second quarter 2019 and recent weeks include:"
05/07/2019 8-K Quarterly results
Docs: "Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update JERUSALEM – Intec Pharma Ltd. today announces financial results for the three months ended March 31, 2019 and provides a corporate update. Highlights of the first quarter 2019 and recent weeks include: ● Announced that the last patient completed their final visit in the Company’ s pivotal Phase 3 trial evaluating the safety and efficacy of the Accordion Pill-Carbidopa/Levodopa compared with immediate release CD/LD as a treatment for the symptoms of advanced Parkinson’ s disease ; ● Reported positive data from a pharmacokinetic study of AP-CD/LD 50/500 mg in PD patients, demonstrating that AP-CD/LD when dosed three times per day met the primary endpoint of reducing plasma levodopa variability when co..."
11/09/2018 6-K Quarterly results
Docs: "FORM 6-K",
"Intec Pharma Reports Third Quarter 2018 Financial Results and Corporate Update",
"Unaudited Condensed Interim Financial Information for the Period Ended September 30, 2018",
"Management’ s Discussion and Analysis of Financial Condition and Results of Operation for the Period Ended September 30, 2018"
08/15/2018 6-K Quarterly results
Docs: "6-K",
"Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update",
"Unaudited Condensed Consolidated Interim Financial Information for the Period Ended June 30, 2018",
"Management’ s Discussion and Analysis of Financial Condition and Results of Operation for the Period Ended June 30, 2018"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy